日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Companies

Chinese biotech firm Beroni partners Aussie university to trial anti-cancer molecule

Xinhua | Updated: 2018-03-29 13:12
Share
Share - WeChat

SYDNEY - A groundbreaking new cancer drug with the power to shrink tumours could soon provide an alternative to chemotherapy.

Known as PENAO, the drug developed by a company called Cystemix at the University of New South Wales (UNSW) in Sydney, has shown extremely promising results in earlier testing.

On Wednesday, Chinese biotech firm, the Beroni Group, signed an agreement to fund phase two human trials and advance the clinical development of the potentially life-saving treatment.

"We know that this drug is going to benefit people," founder of the Beroni Group Jacky Zhang told Xinhua.

The collaboration between UNSW and the Tianjin based firm was made possible by the Torch innovation program to promote China-Australia ties in the technology space.

Zhang considers it a mission of the Beroni Group to promote cooperation between Australia and China in biotechnology, in order to draw on the widest possible range of medical expertise.

"We're great in Australia at coming up with novel ideas and novel therapies but we don't have the funding or the support or the expertise to take it from the laboratory through commercialisation to market," director of knowledge exchange at UNSW Warwick Dawson explained.

"Public funding of research only gets technologies to a certain point, but to prove efficacy in human trials we typically need private support."

"That's why today is so exciting, we have found a commercial partner who will enable us to hopefully get these technologies out of the laboratory and into the clinic for therapeutic use."

For the creator of the breakthrough medicine, Wednesday's event to confirm the next phase of testing was the culmination of 15 years of dedicated work.

"To take a molecule from that inception through all the development in the laboratory, through all the processes that you need to go through to actually test it in humans, it's been a hell of a ride!" Professor Philip Hogg said.

"It's an enormously challenging and difficult process, from really just an idea in the lab, now to really being able to test whether this idea is going to help patients."

Hogg explained that the way the drug works is by preventing tumor cells from dividing.

"Healthy cells in our body, they use sugar mostly to make energy," he said.

"Tumour cells are not fussed about making energy, what they want to do is make new tumour cells."

"So what this molecule that we've made does is it stops the tumor cells from metabolising the sugar in the way that they want and as a result, they can't divide and then if that block goes on for long enough they die."

The trial will likely be performed on 15-20 pancreatic cancer patients to find out whether it improves their survival and wellbeing.

"We are hoping this will form an effective therapy in a space where there really currently isn't any," Hogg said.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 黄色亚洲视频 | 国产成人禁片免费观看 | 亚洲综合欧美日韩 | 久久亚洲一区二区 | 波多野结衣在线看片 | 精品一区二区三区免费站 | 国产成人综合一区二区三区 | 五月天香蕉 | 免费久久网站 | 欧美黄一片 | 亚洲天堂一区二区三区 | 日韩欧美在线观看 | 国产精品色 | 欧美色性 | 欧美日韩精品一区二区在线播放 | 国精品人妻无码一区二区三区性色 | 精品久久九九 | 四虎在线视频 | 日韩色区| 国产色综合一区二区三区 | 久久99国产精一区二区三区 | 国产成人91精品 | 五月婷婷六月丁香 | 欧美日韩综合一区 | 日韩激情视频在线 | 国产综合成色在线视频 | 亚洲精品一区二区网址 | 国产乱码一区二区三区四 | 欧美第一页草草影院 | 高清国产美女一级a毛片 | 5月激情网 | 热久久成人 | 欧美成人午夜在线全部免费 | 国产中文字幕网 | 成人 精品 | 日本久草视频 | 日韩在线观看一区二区不卡视频 | 性夜a爽黄爽 | a级毛片观看 | 九九久久精品 | 91视频高清 |